Halozyme Therapeutics Inc.

(HALO) Trade

By |

Profile

Halozyme Therapeutics Inc is a biopharmaceutical company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.

Contact Information

Website: www.halozyme.com
Email: kgustafson@halozyme.com
Main Phone: +1 858 794-8889
Address: 11388 Sorrento Valley Road
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NGS
Employees: 216
NAICS: Biological Produ
$ 14.29 $ 0. (0.00%)
Last Price 14.29 Change $ 0. Change % 0.00 Tick N/A
Bid 12.71 Bid Size 200.00 Ask 12.72 Ask Size 100.00
Open N/A High N/A Low N/A Prev Close 14.29
Last Trade Volume 101,660 52 Wk Hi 15.20 52 Wk Low 7.70
Market Cap 1.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 129,801,310.00 EPS (TTM) -0.82 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 54
Number of Buys 17 40
Number of Sells 3 14
Net Activity -524462 419267
Last 10 Buys Shares
Laurie Stelzer 1,000
Kathryn E. Falberg 1,000
Kathryn E. Falberg 1,000
Robert L. Engler 1,000
James P. Shaffer 1,000
Kathryn E. Falberg 1,000
Kenneth J. Kelley 1,000
Gregory I. Frost 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Last 10 Sell Shares
Kenneth J. Kelley 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Kenneth J. Kelley 1,000
Robert L. Engler 1,000
Robert L. Engler 1,000
John S. Patton 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16 16 16 16
Low Target Price Estimate 6.75 6.75 6.75 6.75
Mean Target Price Estimate 12.58 12.58 12.58 12.58
Standard Deviation 5.08 5.08 5.08 5.08
Date of Most Recent Estimate 08/10/16 06/10/16 06/10/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.75 1.6 1.6 1.6